Hai-Tao Huang

CanSino Biologics Inc.

Tianjin

China

SCHOLARLY PAPERS

4

DOWNLOADS

709

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Number of pages: 26 Posted: 04 Jan 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 452 (120,216)
Citation 1

Abstract:

Loading...

Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial

2.

Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial

Number of pages: 24 Posted: 30 Dec 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Medical University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 118 (434,707)

Abstract:

Loading...

3.

Safety and Immunogenicity of Heterologous and Homologous Boosting with Orally Aerosolized or Intramuscular Ad5-nCoV and Inactivated Vaccines in Children and Adolescents: A Randomized, Open-Label, Parallel Controlled, Single-Center Study

Number of pages: 20 Posted: 20 Dec 2022
Hunan Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, Hunan Provincial Center for Disease Control and Prevention, Academy of Military Medical Sciences - Institute of Biotechnology, Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, CanSino Biologics Inc., Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Hunan Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, Beijing Institute of Biotechnology, CanSino Biologics Inc., CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Hunan Provincial Center for Disease Control and Prevention and Southern Medical University - Neonatal Intensive Care Unit
Downloads 87 (535,388)

Abstract:

Loading...

COVID-19 vaccine, mucosal vaccine, children, adolescents, clinical trial

4.

Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (Adenovirus Type 5 Vector) as Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: An Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial

Number of pages: 31 Posted: 18 Mar 2024
Institute for Clinical Research, CanSino Biologics Inc., Hospital Kuala Lumpur, Selayang Hospital, CanSino Biologics Inc., CanSino Biologics Inc., Institute for Clinical Research, Academy of Military Medical Sciences - Institute of Biotechnology, Hospital Kuala Lumpur, Selayang Hospital, Institute for Clinical Research, Hospital Kuala Lumpur, CanSino Biologics Inc., University of Malaya (UM), Academy of Military Medical Sciences - Institute of Biotechnology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., CanSino Biologics Inc., Clin Research Private Enterprise, CanSino Biologics Inc., Institute for Clinical Research and Independent
Downloads 52 (702,412)

Abstract:

Loading...

COVID-19 vaccines, inhaled vaccines, immunogenicity, SARS-CoV-2, Ad5-CoV, aerosol inhalation, booster